Breye Therapeutics
Phase 1Addressing the large unmet medical need to develop more effective and less burdensome therapies for patients and their caregivers.
Founded
2020
Focus
Small Molecules
About
Addressing the large unmet medical need to develop more effective and less burdensome therapies for patients and their caregivers.
Funding History
2Total raised: $20.5M
Series A$15MNovo HoldingsOct 15, 2023
Seed$5.5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2020
LocationCopenhagen, Denmark
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile